Average Co-Inventor Count = 10.46
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Healthcare LLC (3 from 780 patents)
2. Bayer Intellectual Property Gmbh (3 from 721 patents)
3. Bayer Corporation (1 from 1,008 patents)
4. Glaxosmithkline LLC (1 from 356 patents)
5. Bayer Pharmaceuticals Corporation (1 from 70 patents)
9 patents:
1. RE46856 - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
2. 8859572 - Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
3. 8466283 - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
4. 8076488 - Bicyclic urea derivatives useful in the treatment of cancer and other disorders
5. 7981903 - 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer
6. 7625915 - Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
7. 7557129 - Cyanopyridine derivatives useful in the treatment of cancer and other disorders
8. 7329670 - Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
9. 6344476 - Inhibition of p38 kinase activity by aryl ureas